CLINICAL_TRIALS
trial_result
· 2014-01-01
Clinical Trial Update: Ranibizumab for Myopic Neovascularization [Phase 4]
Summary
A Phase 4 clinical trial evaluating ranibizumab for myopic choroidal neovascularization is underway, with the trial status currently unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Instituto de Olhos de Goiania | Conditions: Myopic Choroidal Neovascularization | Phase 4 | Status: UNKNOWN